Type I Interferon Signaling In Malignant Blasts Contributes To Treatment Efficacy In Aml Patients

Holicek, P., Truxova, I., Rakova, J., Salek, C., Hensler, M., Kovar, M., Reinis, M., Mikyskova, R., Pasulka, J., Vosahlikova, S., Remesova, H., Valentova, I., Lysak, D., Holubova, M., Kaspar, P., Prochazka, J., Kasikova, L., Spisek, R., Galluzzi, L., and Fucikova, J. Type I Interferon Signaling In Malignant Blasts Contributes To Treatment Efficacy In Aml Patients. Cell Death and Disease, 2023:14:209. Mar-23.

Date

BioLife Solutions logo

This website uses cookies to ensure you get the best experience on our website.